BackAldeyra Therapeutics Overview

Aldeyra Therapeutics Current Assets

Aldeyra Therapeutics's current assets is $47T.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$47378.91B
↓ 43.97% YoYΔ $-37179.32B vs prior year quarter

Peer trimmed avg / median

Loading

Aldeyra Therapeutics Current Assets History

Loading

Aldeyra Therapeutics vs. peers: Current Assets Comparison

Loading

Aldeyra Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aldeyra Therapeutics (ALDX) FAQ

As of the most recent data (June 2026), ALDX shows a current assets of $47T. That compares with $85T in the prior-year period — down 44.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALDX's current assets is now $47T (was $85T) — a 44.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aldeyra Therapeutics is outperforming or lagging.

Tracking ALDX's current assets over time shows whether Aldeyra Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $47T That compares with $85T in the prior-year period — down 44.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Aldeyra Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $47T) with ownership activity and broader fundamentals.

Aldeyra Therapeutics's current assets is $47T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.